Samsara BioCapital, LLC - CUREVAC N V ownership

CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 120 filers reported holding CUREVAC N V in Q2 2021. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.

Quarter-by-quarter ownership
Samsara BioCapital, LLC ownership history of CUREVAC N V
ValueSharesWeighting
Q1 2021$8,718,000
+12.8%
95,3180.0%1.61%
+106.9%
Q4 2020$7,727,000
-55.2%
95,318
-74.3%
0.78%
-83.8%
Q3 2020$17,241,000370,3854.81%
Other shareholders
CUREVAC N V shareholders Q2 2021
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,709,781$23,300,00017.91%
Pinz Capital Management, LP 40,200$547,0000.38%
Parametrica Management Ltd 13,513$184,0000.20%
MQS Management LLC 16,176$220,0000.15%
Quantamental Technologies LLC 11,552$157,0000.07%
Ergoteles LLC 98,100$1,335,0000.04%
Virtus ETF Advisers LLC 7,676$104,0000.04%
Green Alpha Advisors, LLC 12,247$167,0000.04%
ETF MANAGERS GROUP, LLC 53,789$746,0000.02%
Quantbot Technologies LP 14,800$201,0000.02%
View complete list of CUREVAC N V shareholders